BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26505753)

  • 1. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
    Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
    PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
    Wampfler R; Hofmann NE; Karl S; Betuela I; Kinboro B; Lorry L; Silkey M; Robinson LJ; Mueller I; Felger I
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005753. PubMed ID: 28732068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
    Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
    PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
    Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
    Betuela I; Rosanas-Urgell A; Kiniboro B; Stanisic DI; Samol L; de Lazzari E; Del Portillo HA; Siba P; Alonso PL; Bassat Q; Mueller I
    J Infect Dis; 2012 Dec; 206(11):1771-80. PubMed ID: 22966124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
    Campo B; Vandal O; Wesche DL; Burrows JN
    Pathog Glob Health; 2015 May; 109(3):107-22. PubMed ID: 25891812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
    Hwang J; Alemayehu BH; Reithinger R; Tekleyohannes SG; Takele Teshi ; Birhanu SG; Demeke L; Hoos D; Melaku Z; Kassa M; Jima D; Malone JL; Nettey H; Green M; Poe A; Akinyi S; Udhayakumar V; Kachur SP; Filler S
    PLoS One; 2013; 8(5):e63433. PubMed ID: 23717423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
    Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
    Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
    PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
    Phommasone K; van Leth F; Imwong M; Henriques G; Pongvongsa T; Adhikari B; Peto TJ; Promnarate C; Dhorda M; Sirithiranont P; Mukaka M; Peerawaranun P; Day NPJ; Cobelens F; Dondorp AM; Newton PN; White NJ; von Seidlein L; Mayxay M
    Malar J; 2020 Jan; 19(1):4. PubMed ID: 31900172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
    Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
    Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    Nekkab N; Lana R; Lacerda M; Obadia T; Siqueira A; Monteiro W; Villela D; Mueller I; White M
    PLoS Med; 2021 Apr; 18(4):e1003535. PubMed ID: 33891582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria.
    Karl S; Laman M; Moore BR; Benjamin JM; Salib M; Lorry L; Maripal S; Siba P; Robinson LJ; Mueller I; Davis TM
    Acta Trop; 2016 Aug; 160():1-8. PubMed ID: 27056132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Marginal Case of Malaria: An Interesting Malaria Story of Cameroon Origin].
    Erdoğan E; Türe Yüce Z; Ayrık Demir A; Yaman O; Yürük M; Yıldız O
    Mikrobiyol Bul; 2023 Jul; 57(3):498-505. PubMed ID: 37462313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.